Advances in the Management of Platinum-Sensitive Relapsed Ovarian Cancer

被引：28
|
作者：
Bouberhan, Sara [1 ,2 ]
Pujade-Lauraine, Eric [3 ]
Cannistra, Stephen A. [1 ,2 ]
机构：
[1] Beth Israel Deaconess Med Ctr, 330 Brookline Ave,KS 113, Boston, MA 02215 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Assoc Res Canc Including Gynecol, Grp Natl Investigators Study Ovarian Canc & Breas, Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 27期
关键词：
RECURRENT EPITHELIAL OVARIAN; OLAPARIB MAINTENANCE THERAPY; BRCA2 REVERSION MUTATIONS; CELL-FREE DNA; DOUBLE-BLIND; PRIMARY PERITONEAL; PHASE-3; TRIAL; OPEN-LABEL; CHEMOTHERAPY; BEVACIZUMAB;
D O I：
10.1200/JCO.19.00314
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2424 / +
页数：14
相关论文
共 50 条
  • [1] Platinum-sensitive ovarian cancer: liminal advances
    Penson, Richard T.
    [J]. LANCET ONCOLOGY, 2020, 21 (05): : 614 - 615
  • [2] Management of platinum-sensitive recurrent ovarian cancer
    Pfisterer, Jacobus
    Ledermann, Jonathan A.
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (02) : S12 - S16
  • [3] Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
    Ledermann, Jonathan
    Harter, Philipp
    Gourley, Charlie
    Friedlander, Michael
    Vergote, Ignace
    Rustin, Gordon
    Scott, Clare
    Meier, Werner
    Shapira-Frommer, Ronnie
    Safra, Tamar
    Matei, Daniela
    Macpherson, Euan
    Watkins, Claire
    Carmichael, James
    Matulonis, Ursula
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15): : 1382 - 1392
  • [4] MANAGEMENT OF FIRST RELAPSE IN PLATINUM-SENSITIVE OVARIAN CANCER
    Vieira, C.
    Teixeira, A.
    Vaz, A.
    Ferreira, A.
    Oliveira, J.
    Couto, R.
    Afonso, N.
    Sousa, S.
    Sousa, B.
    Pereira, D.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 215 - 215
  • [5] Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
    Ledermann, Jonathan A.
    Pujade-Lauraine, Eric
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11
  • [6] Is single-agent chemotherapy acceptable in platinum-sensitive relapsed ovarian cancer?
    Abou-Jawde, Rony M.
    Oberoi, Satinderjit S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) : 2602 - 2603
  • [7] Olaparib in Platinum-Sensitive Ovarian Cancer
    Kaji, Daisuke
    Miura, Yuji
    Takano, Toshimi
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02): : 179 - 179
  • [8] Is single-agent chemotherapy acceptable in platinum-sensitive relapsed ovarian cancer? Reply
    Ferrandina, Gabriella
    Ludovisi, Manuela
    Scambia, Giovanni
    Pignata, Sandro
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) : 2603 - 2603
  • [9] Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer
    Armstrong, Deborah K.
    White, Allen J.
    Weil, Susan C.
    Phillips, Martin
    Coleman, Robert L.
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 129 (03) : 452 - 458
  • [10] Quality of life during olaparib maintenance therapy in platinum-sensitive relapsed serous ovarian cancer
    Jonathan A Ledermann
    Philipp Harter
    Charlie Gourley
    Michael Friedlander
    Ignace Vergote
    Gordon Rustin
    Clare Scott
    Werner Meier
    Ronnie Shapira-Frommer
    Tamar Safra
    Daniela Matei
    Anitra Fielding
    Bryan Bennett
    David Parry
    Stuart Spencer
    Helen Mann
    Ursula Matulonis
    [J]. British Journal of Cancer, 2016, 115 : 1313 - 1320
12345